Phreesia Inc’s recent filing unveils that its SVP, Life Sciences Linetsky David unloaded Company’s shares for reported $5991.0 on Apr 21 ’25. In the deal valued at $23.04 per share,260 shares were sold. As a result of this transaction, Linetsky David now holds 8,752 shares worth roughly $0.21 million.
Then, Hui Yvonne sold 1,330 shares, generating $31,521 in total proceeds. Upon selling the shares at $23.70, the Principal Accounting Officer now owns 22,592 shares.
Before that, Hui Yvonne sold 993 shares. Phreesia Inc shares valued at $22,881 were divested by the Principal Accounting Officer at a price of $23.04 per share. As a result of the transaction, Hui Yvonne now holds 23,922 shares, worth roughly $0.58 million.
RBC Capital Mkts upgraded its Phreesia Inc [PHR] rating to an Outperform from a a Sector perform in a research note published on January 08, 2025; the price target was increased to $32 from $24. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late February with a ‘”a Buy”‘ rating. DA Davidson also remained covering PHR and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Barclays started covering the stock on January 03, 2024. It rated PHR as “an Overweight”.
Price Performance Review of PHR
On Friday, Phreesia Inc [NYSE:PHR] saw its stock fall -1.15% to $24.06. Over the last five days, the stock has lost -5.28%. Phreesia Inc shares have fallen nearly -4.37% since the year began. Nevertheless, the stocks have risen 1.86% over the past one year. While a 52-week high of $30.53 was reached on 02/14/25, a 52-week low of $17.07 was recorded on 03/10/25. SMA at 50 days reached $25.33, while 200 days put it at $24.24.
Levels Of Support And Resistance For PHR Stock
The 24-hour chart illustrates a support level at 23.73, which if violated will result in even more drops to 23.41. On the upside, there is a resistance level at 24.36. A further resistance level may holdings at 24.67. The Relative Strength Index (RSI) on the 14-day chart is 39.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.56%. Stochastics %K at 10.61% indicates the stock is a buying.
The most recent change occurred on April 12, 2023 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $37 price target.
